Manufacturers Life Insurance Company, The Kymera Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $103 Billion
- Q1 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 114,757 shares of KYMR stock, worth $3.43 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
114,757
Previous 100,073
14.67%
Holding current value
$3.43 Million
Previous $2.55 Million
81.12%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding KYMR
# of Institutions
164Shares Held
63.1MCall Options Held
39.7KPut Options Held
9.7K-
Price T Rowe Associates Inc Baltimore, MD6.33MShares$189 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$179 Million3.05% of portfolio
-
Atlas Venture Life Science Advisors, LLC5.38MShares$161 Million27.05% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$154 Million6.22% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.77MShares$142 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $1.63B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...